Tevogen Bio Holdings Inc (TVGN) Stock Analysis

Tevogen Bio Holdings Inc (TVGN) is a publicly traded company in the HEALTHCARE sector. It trades at $8.77, carries a market capitalization of $33.71M. This page summarizes the public market data, fundamentals, and frequently asked questions for TVGN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Tevogen Bio Holdings Inc currently has a Bullish sentiment score of 0.43.

About Tevogen Bio Holdings Inc

Tevogen Bio Holdings Inc. (TVGN) is an innovative clinical-stage biotechnology firm located in Warren, New Jersey, dedicated to developing off-the-shelf precision T cell therapeutics targeting critical unmet medical needs in virology, oncology, and neurology. By leveraging cutting-edge immunotherapy methods, Tevogen Bio aims to transform treatment paradigms and improve patient outcomes through enhanced accessibility to advanced therapies. The company's focus on harnessing the immune system's ...

GNG Research Analysis

GNG Research scores Tevogen Bio Holdings Inc (TVGN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TVGN.

Frequently Asked Questions

Does TVGN pay dividends?

Tevogen Bio Holdings Inc (TVGN) does not currently pay a regular dividend.

What is TVGN's market cap?

Tevogen Bio Holdings Inc (TVGN) has a market capitalization of $33.71M with a current stock price of $8.77.